Robeco Institutional Asset Management B.V. Catalyst Pharmaceuticals, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 03, 2023	BUY	$14.34 - $21.05 $162,974 - $239,233	11,365 Added 20.69%	66,304 $1.1 Million
Q3 2022 Oct 26, 2022	BUY	$7.06 - $15.52 $387,869 - $852,653	54,939 New	54,939 $704,000

Others Institutions Holding CPRX

# of Institutions

327

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

Black Rock Inc. New York, NY

18.7M
Shares

$424 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

8.04M
Shares

$182 Million
0.0% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

6.23M
Shares

$141 Million
2.3% of portfolio
State Street Corp Boston, MA

5.69M
Shares

$129 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

3.02M
Shares

$68.4 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account